Long-term outcome in corneal endotheliitis with molecular detection of herpes simplex virus 1 and human herpes virus 6: a case report.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
02 Feb 2022
Historique:
received: 27 05 2021
accepted: 25 01 2022
entrez: 2 2 2022
pubmed: 3 2 2022
medline: 4 2 2022
Statut: epublish

Résumé

Human herpesvirus 6B (HHV-6B) is known to cause exanthema subitem and has been detected in various ocular diseases, including keratitis, uveitis, optic neuritis, and endophthalmitis; however, the long-term outcome after the reactivation of HHV-6B has not been well-addressed. Sugita et al. previously reported the concomitant presence of HHV-6B with herpes simplex virus-1 (HSV-1) in the aqueous fluid at the onset of corneal endotheliitis. We focused on the same patient with corneal endotheliitis, in whom both HSV-1 and HHV-6B sequences were observed, and reported the clinical course and long-term outcomes. A 64-year-old woman was referred to our center for visual disturbances in the left eye. Her best-corrected visual acuity in the left eye was 0.5 and the left intraocular pressure was elevated to 33 mmHg. Mid-sized keratic precipitates and 2+ cells were observed in the anterior chamber with corneal endothelial edema and reduction of the corneal endothelial cell density to 1828 cells/mm Reactivation of HHV-6B infection might be associated with HSV-1 corneal endotheliitis; however, no serious late sequelae occurred after appropriate treatment for HSV-1 infection in this immunocompetent host.

Sections du résumé

BACKGROUND BACKGROUND
Human herpesvirus 6B (HHV-6B) is known to cause exanthema subitem and has been detected in various ocular diseases, including keratitis, uveitis, optic neuritis, and endophthalmitis; however, the long-term outcome after the reactivation of HHV-6B has not been well-addressed. Sugita et al. previously reported the concomitant presence of HHV-6B with herpes simplex virus-1 (HSV-1) in the aqueous fluid at the onset of corneal endotheliitis. We focused on the same patient with corneal endotheliitis, in whom both HSV-1 and HHV-6B sequences were observed, and reported the clinical course and long-term outcomes.
CASE PRESENTATION METHODS
A 64-year-old woman was referred to our center for visual disturbances in the left eye. Her best-corrected visual acuity in the left eye was 0.5 and the left intraocular pressure was elevated to 33 mmHg. Mid-sized keratic precipitates and 2+ cells were observed in the anterior chamber with corneal endothelial edema and reduction of the corneal endothelial cell density to 1828 cells/mm
CONCLUSIONS CONCLUSIONS
Reactivation of HHV-6B infection might be associated with HSV-1 corneal endotheliitis; however, no serious late sequelae occurred after appropriate treatment for HSV-1 infection in this immunocompetent host.

Identifiants

pubmed: 35105322
doi: 10.1186/s12886-022-02274-5
pii: 10.1186/s12886-022-02274-5
pmc: PMC8808982
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48

Informations de copyright

© 2022. The Author(s).

Références

Am J Ophthalmol. 2020 May;213:252-259
pubmed: 31785234
Arch Dermatol. 1998 Sep;134(9):1113-7
pubmed: 9762024
Neurol Neuroimmunol Neuroinflamm. 2021 Jan 12;8(2):
pubmed: 33587722
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9096-9
pubmed: 23674671
Arch Dermatol. 1998 Sep;134(9):1108-12
pubmed: 9762023
Retin Cases Brief Rep. 2013 Spring;7(2):131-3
pubmed: 25390803
Cell. 1999 Dec 23;99(7):817-27
pubmed: 10619434
Cornea. 2014 Nov;33 Suppl 11:S3-8
pubmed: 25170583
J Infect. 2007 Apr;54(4):e237-40
pubmed: 17303245
Semin Ophthalmol. 2008 Jul-Aug;23(4):235-40
pubmed: 18584561
J Clin Microbiol. 1989 Apr;27(4):651-3
pubmed: 2542358
Lancet. 1988 May 14;1(8594):1065-7
pubmed: 2896909
Int Ophthalmol. 2019 Dec;39(12):2785-2795
pubmed: 31134426
J Ophthalmic Inflamm Infect. 2014 Jun 19;4:16
pubmed: 24995045
Science. 1986 Oct 31;234(4776):596-601
pubmed: 2876520
Arch Virol. 2014 May;159(5):863-70
pubmed: 24193951
Invest Ophthalmol Vis Sci. 2012 Jul 12;53(8):4692-8
pubmed: 22700707

Auteurs

Takashi Ono (T)

Miyata Eye Hospital, 6-3, Kuraharacho, Miyakonojo, Miyazaki, 885-0051, Japan. taono-tky@umin.ac.jp.
Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. taono-tky@umin.ac.jp.

Takuya Iwasaki (T)

Miyata Eye Hospital, 6-3, Kuraharacho, Miyakonojo, Miyazaki, 885-0051, Japan.

Yukiko Terada (Y)

Miyata Eye Hospital, 6-3, Kuraharacho, Miyakonojo, Miyazaki, 885-0051, Japan.
Department of Ophthalmology, Tokyo Metropolitan Geriatric Medical Center, Tokyo, Japan.

Yosai Mori (Y)

Miyata Eye Hospital, 6-3, Kuraharacho, Miyakonojo, Miyazaki, 885-0051, Japan.

Ryohei Nejima (R)

Miyata Eye Hospital, 6-3, Kuraharacho, Miyakonojo, Miyazaki, 885-0051, Japan.

Mineo Ozaki (M)

Ozaki Eye Hospital, Miyazaki, Japan.

Manabu Mochizuki (M)

Miyata Eye Hospital, 6-3, Kuraharacho, Miyakonojo, Miyazaki, 885-0051, Japan.

Kazunori Miyata (K)

Miyata Eye Hospital, 6-3, Kuraharacho, Miyakonojo, Miyazaki, 885-0051, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH